Skip to content

Search Results

No Matching Results

    Recently Viewed

      Listening...

      HomeLatest newsWhat you need to know about Johnson & Johnson’s 2019 fourth-quarter and full-year earnings report
      FINAL LEDE- What You Need to Know About Johnson & Johnson's 2019 Fourth Quarter and Full-Year Earnings Report- Q4 Earnings 2019

      What you need to know about Johnson & Johnson’s 2019 fourth-quarter and full-year earnings report

      Check out this infographic breakdown of the company’s fourth quarter and annual earnings report, with key performance highlights from its pharmaceutical, consumer and medical devices businesses.

      Share Article
      share to
      fourth-quarter-and-full-year-earnings-banner-0122.png

      Johnson & Johnson shared financial information this morning about its fourth quarter and full-year performance in 2019.

      Since its founding in 1886, the company has grown to become one of the world’s largest and most broadly based healthcare companies, with approximately 132,000 employees across the globe working every day to help change the trajectory of health for humanity.

      “Johnson & Johnson’s 2019 results reflect a solid fourth quarter and full year of strong performance for the company,” says Joe Wolk, Executive Vice President and Chief Financial Officer, Johnson & Johnson. “Throughout 2019, the colleagues of Johnson & Johnson remained focused on executing growth strategies, investing in innovation and delivering transformative healthcare solutions to patients and consumers around the world. Looking ahead to 2020, I am confident that our broad-based business is well positioned to drive strong results and deliver long-term value to all of our stakeholders.”

      For more details about the company’s 2019 fourth quarter and full-year results, and to read a message from Chairman and Chief Executive Officer Alex Gorsky, here’s an infographic packed with key stats.


      2019 EOY/Fourth Quarter Earnings infographic

      Johnson & Johnson’s 2019 Earnings

      Read the earnings press release, which includes fourth quarter and full-year financial data for 2019.

      Want to see more company earnings information? Find several years of Johnson & Johnson quarterly and full-year results here.


      More from Johnson & Johnson

      Meet a nurse who leads clinical trials to find innovative cancer therapies

      Melissa Martinez is a clinical scientist within Johnson & Johnson’s Interventional Oncology R&D group. Not only is she helping to develop lifesaving treatments, she’s redefining what it means to pursue a career in nursing.

      What’s the difference between IBS and IBD?

      These GI conditions sound similar, and they also share some symptoms. But IBS and IBD are distinct disorders—especially when it comes to treatment and the risk of complications.

      What is IL-23?

      This pro-inflammatory protein is the target of potential Johnson & Johnson medications that could help treat autoimmune conditions such as psoriasis, inflammatory bowel disease and rheumatoid arthritis.
      You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.